Latest Content

Transitioning from active cancer treatment brings a new kind of uncertainty. Learn how to navigate life when the medical guardrails are removed.

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term follow-up care strategies.

Dr. Ramy Sedhom highlights screening and care pathways that improve outcomes and strengthen psychosocial support for patients with cancer.

Diagnosed with both AIDS and cancer, a writer finds solace in the Cape May surf and the profound gift of a friend truly engaging with his life’s work.

KRAS was long thought undruggable in cancer until scientists discovered a hidden binding pocket in mutant KRAS, leading to targeted therapies.

New immunotherapy use before and after surgery improves outcomes, making early symptom recognition and expert care more critical than ever.

Dr. Ramy Sedhom discusses how embedded psychosocial care in oncology may improve access, engagement and emotional support during cancer care.

Urologist Dr. Susan MacDonald breaks down the differences between soft tissue and blood cancers while highlighting common and rare disease types.

Phase 3 trial shows Datroway significantly extended overall and progression-free survival in patients with previously untreated, advanced TNBC ineligible for immunotherapy.

Dr. Tony Anderson speaks about fertility preservation options for men and women before cancer treatment, emphasizing early testing and timely referral.

A healthcare provider shares her journey with multiple myeloma, discussing the physical, emotional and financial challenges of living with cancer.

Colorectal cancer is rising in younger adults. Dr. Jeremy Kortmansky, discusses causes, symptoms, screening barriers, and prevention.

FDA reviews Ziihera combinations for HER2-positive gastroesophageal cancer, showing potential benefit as a first-line treatment option for patients.